SCHEMBL21058281

SCHEMBL21058281

O=P(O)(O)OP(O)(=S)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(NCc4ccco4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 4/20 0.70
▸ P2RX2 Q9UBL9 4/20 0.70
▸ NT5E P21589 3/20 0.68
▸ TP53 P04637 2/20 0.66
▸ PAX8 Q06710 2/20 0.66
▸ SMN1; SMN2 Q16637 2/20 0.66
▸ ADORA3 P0DMS8 1/20 0.66
▸ SLC29A1 Q99808 1/20 0.66
▸ MITF O75030 1/20 0.66
▸ LMNA P02545 1/20 0.66
▸ DNPH1 O43598 2/20 0.64
▸ P2RX4 Q99571 2/20 0.63
▸ P2RY1 P47900 4/20 0.61
▸ P2RY2 P41231 3/20 0.61
▸ P2RY12 Q9H244 2/20 0.61
▸ P2RY6 Q15077 1/20 0.61
▸ GPR17 Q13304 1/20 0.58
▸ SRC P12931 1/20 0.55
▸ P2RX1 P51575 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4058981 0.90 DNPH1 (0.77) P2RX3P2RX2NT5ETP53PAX8
SCHEMBL21058279 0.85 P2RX3 (0.76) P2RX3P2RX2NT5EADORA3DNPH1
SCHEMBL21058282 0.84 P2RX3 (0.88) P2RX3P2RX2NT5ESMN1; SMN2SLC29A1
SCHEMBL13033867 0.83 P2RX3 (0.98) P2RX3P2RX2NT5ETP53ADORA3
SCHEMBL4319955 0.83 P2RX3 (0.98) P2RX3P2RX2NT5ETP53ADORA3
SCHEMBL30076630 0.83 P2RX3 (0.98) P2RX3P2RX2NT5ETP53ADORA3
SCHEMBL29941330 0.83 P2RX3 (0.98) P2RX3P2RX2NT5ETP53ADORA3
SCHEMBL9607782 0.83 P2RX3 (0.98) P2RX3P2RX2NT5ETP53ADORA3
SCHEMBL15794372 0.83 P2RX3 (1.00) P2RX3P2RX2NT5ETP53ADORA3
SCHEMBL14178287 0.83 P2RX3 (1.00) P2RX3P2RX2NT5ETP53ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190185906-A1 IN SITU VISUALIZATION OF KINASE ACTIVITY DANA-FARBER CANCER INSTITUTE, INC. 2019-06-20 — — US claimed
US-20190185906-A1 IN SITU VISUALIZATION OF KINASE ACTIVITY DANA-FARBER CANCER INSTITUTE, INC. 2019-06-20 — — US disclosed
Send feedback